InSightec’s Focused Ultrasound Shows Early, Positive Data For Disabling Tremor

The results are an encouraging sign not only for the company but also for the novel device development model employed by the trial’s sponsor, the Focused Ultrasound Foundation.

InSightec Ltd.’s ExAblate Neuro magnetic resonance focused ultrasound system showed promise as a treatment for severe tremors in early-stage data reported this week. The results are an encouraging sign for the company and the novel device development model employed by the trial’s sponsor, the Focused Ultrasound Foundation.

Results of the 15-patient trial

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D